Stage Iv Anal Canal Cancer: Disease Bioinformatics
Anal Cancer, or anal canal cancer, begins in the anus and is typically curable, however its specific location, size, and nodal status are large factors in its treatment. Anal Cancer is highly uncommon as it only accounts for 4% of all cancers of the lower alimentary track. Of the approximate 4,000 cases reported each year in the United States, around 85% of victims are Caucasian with an average age of 62. Individuals who have many sexual partners and may be exposed to the human papillomavirus (HPV) have a higher chance of being diagnosed with anal cancer as HPV is highly associated with the onset of anal cancer. Stage IV of anal canal cancer is characterized as when the cancer has spread to locations thoughout the body such as various organs, tissues, and lymph nodes without size limitations. Stage IV is considered to be the most aggressive stage of anal cancer.
Stage Iv Anal Canal Cancer Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Stage Iv Anal Canal Cancer below!
For more information on how to use Laverne, please read the How to Guide.
We have 269 products for the study of Stage Iv Anal Canal Cancer that can be applied to Western Blot, Immunocytochemistry/Immunofluorescence, Flow Cytometry, Immunohistochemistry from our catalog of antibodies and ELISA kits.